Context: In healthy adults with detectable cold-induced brown adipose tissue activation (CIBA), the relationships between sympathetic nervous system (SNS) or thyroid activity during energy balance (EBL) with CIBA and body composition change are undetermined.
O besity is the result of sustained energy intake exceeding energy expenditure (EE). Brown adipose tissue (BAT), a thermogenic tissue that dissipates energy (1), may be a contributor of daily EE and may play a role in regulating weight or body composition changes. The sympathetic nervous system (SNS) is a primary regulator of BAT function via promotion of brown preadipocyte proliferation and activation of beta-adrenergic receptors on mature brown adipocytes (1, 2) . Sympathetic activation of BAT results in nonshivering thermogenesis in response to cold exposure, a powerful stimulus of BAT, in both rodents and humans (3) (4) (5) .
Cold-induced BAT activation (CIBA) can be quantified through positron emission tomography (PET) scans in adult humans and is associated with increased EE (6) (7) (8) . The thermogenic properties of BAT make it an intriguing target for tackling obesity (9) ; however, the relationship of CIBA to change in weight or body composition in humans is not well understood. CIBA is inversely associated with measures of adiposity such as body mass index and body fat percentage (3, 4, 10) . We have reported that CIBA, measured in standardized uptake value (SUV), is negatively associated with fat-free mass (FFM) and that subjects with CIBA (SUV $2 g/mL) who have lower activation of BAT are more likely to have an increase in fat mass (FM) after 6 months in free-living conditions (11) . Further, the treatment of 6 weeks with cold exposure in adults with previously undetectable CIBA (,2 g/mL SUV) activates BAT and increases FM loss in those with the greatest increase in CIBA after therapy (12) .
In humans, SNS activity can be assessed by urine or plasma catecholamine measurements (13) . Studies investigating the association between catecholamines and BAT have predominantly examined individuals diagnosed with pheochromocytoma, a tumor in the adrenal medulla that oversecretes catecholamines and causes BAT hypertrophy (14) (15) (16) . In these studies, those with higher plasma catecholamine concentrations have higher BAT activity (17) . However, among healthy individuals, there are no differences in plasma norepinephrine concentrations in those with detectable vs undetectable CIBA (18) . Whether SNS activity measured during thermoneutrality and energy balance (EBL), as a static marker of SNS activity, is associated with CIBA has not been examined in healthy individuals.
Free T3 and free T4 are reduced in individuals with positive BAT activity compared with BAT-negative individuals (19) . A case report has shown the presence of substantial BAT volume in an adolescent with severe primary hypothyroidism, a low thyroid hormone state (20) , that subsequently decreased in volume after 2 months of treatment with levothyroxine. However, this study used infrared thermal imaging and MRI techniques rather than gold-standard PET/CT to quantify BAT activity within the supraclavicular region. Conversely, in a hyperthyroid state, excess thyroid hormone concentrations increase BAT activity in rodents and humans (21, 22) . These studies indicate that thyroid hormones are a potential regulator of BAT in humans, and additional investigation in healthy subjects with normal thyroid function is warranted.
To further understand the role of the SNS and thyroid hormones in humans with cold-induced activation of BAT, we evaluated the relationships between CIBA and the SNS and thyroid function by assessing 24-hour urinary catecholamines and plasma thyroid hormones (free T3 and free T4) measured during EBL and thermoneutrality in healthy individuals with CIBA .2 SUV (11). In so doing, we aimed to establish a means to identify subjects who have greater potential for cold-induced BAT that might allow for detection of those who might benefit from interventions that act via BAT. We also examined whether CIBA, urinary catecholamines, or thyroid hormones predicted weight or body composition changes after 6 months in free-living conditions.
Methods

Participants
Fifty-two volunteers between the ages of 18 and 50 years recruited from the Phoenix, AZ metropolitan area between 2009 and 2012, deemed healthy by medical history, physical examination, and laboratory measures, were admitted to the clinical research unit as part of a larger ongoing study (NCT00523627). Thirty-six volunteers were excluded based on PET/CT substudy criteria, which included an age ,18 or .40 years, radiation exposure to the torso within the past 12 months, or declining participation. Of the 16 volunteers who participated in this substudy, 12 participants had measurements of CIBA and thyroid hormones, and 11 had urinary catecholamines analyzed. On admission, volunteers were placed on a weight-maintaining diet (WMD) consisting of 50% carbohydrates, 30% fat, and 20% protein. A 75-g oral glucose tolerance test was performed after 3 days on the WMD, and only volunteers with normal glucose regulation (23) continued the study. Body composition was measured by a dual-energy X-ray absorptiometry scan (DPX-1; Lunar Corp, Madison, WI). Volunteers were invited to return to our unit for follow-up at 6 months to remeasure weight and body composition. All participants provided written and informed consent prior to beginning the study. This study was approved by the Institutional Review Board of the National Institute of Diabetes and Digestive and Kidney Diseases.
EE Measurements
Following 4 days of a WMD, a whole-room indirect calorimeter was used to measure 24-hour EE (24hEE) by an initial eucaloric acclimation session followed by a second eucaloric session for the precise determination of 24hEE, as previously described (24) , in thermoneutrality (mean 6 SD; ambient temperature 23.9 6 1.4°C). Participants were allowed to move freely inside the metabolic chamber, and this activity was measured using radar sensors, expressed as a percentage of time when activity was detected. As part of this study, participants also had 24hEE measured during fasting conditions (participants allowed only water and noncaloric beverages). Diet-induced thermogenesis (DIT) was calculated in two manners, the first as the difference between 24hEE during the eucaloric session and 24hEE during fasting and a second measurement of DIT as previously described (25) .
PET/CT Imaging
Study participants underwent an 18 F-fluorodeoxglucose (18F-FDG) PET/CT scan after a day on a WMD and following an overnight fast. Prior to the scan, volunteers were exposed to mild cold (16°C) for 2 hours while wearing standardized clothing of ;0.3 clo. All possible measures were taken to avoid shivering, and if shivering occurred, the volunteer was removed from the cold room for 5 minutes and then returned into the cold room.
The images were collected 1 hour after injection of 18F-FDG into the antecubital vein (mean dose 14.7 6 0.3 mCi). PET and CT images by the Reveal 16 High Rez (CTI Molecular Imaging, Knoxville, TN) were taken from the diaphragm to the brain, and the images were coregistered with BAT quantified using a statistical parametric mapping software (SPM12; http://www. fil.ion.ucl.ac.uk/spm/software/spm12/) package in MATLAB (The Math Works, Inc.). CIBA was defined as the average SUV activity of the collection of voxels with an SUV of $2.0 in the PET image, coinciding with areas in the CT image with Hounsfield units between 2250 and 210, in which the mean BAT SUV and volume were calculated. PET images were reconstructed into image voxels of 1.95 mm 3 1.95 mm 3 4.00 mm and CT image voxels of 0.98 mm 3 0.98 mm. CIBA SUV (g/mL) was calculated as the activity of BAT (Becquerel) per milliliter of tissue divided by the dose (Becquerels) per gram of body weight. CIBA SUV was further adjusted for FFM by multiplying CIBA SUV to FFM/weight ratio (26) .
Catecholamines and Thyroid Hormones
Urinary catecholamines were collected during the 24hEE measurement, whereas volunteers were in EBL and thermoneutrality as an index of SNS tone activity. Mayo Medical Laboratories (27) measured catecholamines using the HPLC method for epinephrine and norepinephrine and liquid chromatography-tandem mass spectrometry (stable isotope dilution analysis) for metanephrine and normetanephrine. Fasting plasma free T3 and free T4 were collected the morning after EBL and stored in a freezer at 270°C. The batched samples were measured using the EIA kit from Phoenix Pharmaceuticals (Burlingame, CA) by the National Institute of Diabetes and Digestive and Kidney Diseases Laboratory Core in Bethesda, MD. The intra-assay and interassay CV were 3.0% and 4.5% for free T3 and 2.8% and 4.0% free T4, respectively.
Statistical Analyses
Alpha was set at 0.05. Analyses were performed using SAS software (version 9.4; Cary, NC). Data are presented as mean 6 SD, unless otherwise stated. Catecholamines values were log 10 -transformed to meet normal distribution requirements for parametric analysis. Differences between sexes were assessed using Student t test. Pearson correlations were used to assess relationships between continuous variables. Linear models with 24hEE as a dependent variable and FFM as independent variable were used to calculate the residual 24hEE. Similar linear models were used with 24-h mean respiratory quotient (RQ) as the dependent variable and body fat percentage as an independent variable. Due to the small sample size, serial individual partial adjustments were used to verify if associations between CIBA SUV and volume and catecholamine levels were independent of age, sex, body fat percentage, FM, or FFM. To assess weight and body composition changes, linear models were used with weight or FM change as dependent variable and CIBA SUV, catecholamines, or thyroid hormones as independent variables.
Results
CIBA Measurements
Baseline and metabolic characteristics during EBL are shown in Table 1 . Twelve volunteers had positive CIBA 18F-FDG PET/CT scans with a mean CIBA SUV of 3.25 6 0.70 g/mL (range 2.35-4.57) and mean BAT volume of 120.17 6 91.82 cm 3 (range 3.00-289.00 cm 3 ) with no differences by sex (P = 0.23 and P = 0.15, respectively).
Relationship of CIBA to 24hEE and body composition As previously described (11), CIBA was negatively correlated with FFM (r = 20.66; P = 0.02), but not with other baseline body composition measurements. BAT volume was positively associated with body fat percentage and FM (r = 0.76, P , 0.01; and r = 0.74, P , 0.01, respectively; Fig. 1 ). BAT measurements were not associated with 24hEE measured during EBL after adjustment for FFM (CIBA: r = 20.08, P = 0.80; BAT volume: r = 0.19, P = 0.56) or 24-h mean RQ after adjustment for body fat percentage (CIBA: r = 0.25, P = 0.43; BAT volume: r = 0.29, P = 0.36). CIBA was also not associated with either measurement of DIT (both P . 0.21).
Relationship of CIBA measurements to urinary catecholamine concentrations and thyroid hormone measurements
Urinary norepinephrine was not associated with baseline characteristics including age, FFM, FM, body fat percentage, or 24hEE adjusted for FFM (all P . 0.05). CIBA mean SUV was negatively associated with 24-h urinary norepinephrine and normetanephrine concentrations (r = 20.64, P = 0.03; and r = 20.66, P = 0.03, respectively; Fig. 2 ). After adjustment for FFM, the relationship was attenuated, but the directionality remained (r = 20.58, P = 0.07; and r = 20.62, P = 0.05). BAT volume was associated with epinephrine and metanephrine concentrations (r = 20.70, P = 0.02; and r = 20.71, P = 0.02, respectively); however, upon removal of outliers, these results were no longer significant (P . 0.70).
Free T3 was associated with FFM (r = 0.83; P , 0.01), but not with other baseline measurements, including age, weight, and body fat percentage (all P . 0.05). Free T4 was associated with FFM (r = 0.75; P , 0.01) and inversely with body fat percentage (r = 20.69, P = 0.01), but not with other baseline measurements including age (P = 0.56), weight (P = 0.73), and FM (P = 0.07). Both CIBA mean SUV and BAT volume were negatively associated with free T4 (r = 20.75, P = 0.005; and r = 20.73, P = 0.007, respectively), but not free T3 (P = 0.27 and P = 0.37, respectively), such that individuals with higher T4 had lower CIBA. After partial adjustment for FFM, CIBA and BAT volume were still associated with free T4 (r = 20.61, P = 0.05; and r = 20.67, P = 0.02). In a model with both free T4 and urinary norepinephrine, neither were independently associated with CIBA (data not shown), but these results should be interpreted with caution given the small sample size. Pictorial comparisons of the PET/CT scans of the individual with the highest CIBA and the lowest urinary norepinephrine and free T4 vs the individual with the lowest CIBA and the highest free T4 and urinary norepinephrine are shown in Fig. 3 . Sensitivity analyses using nonweighted SUV scores were used, and results were similar (data not shown).
Relationship of 6-month body composition changes to CIBA and urinary catecholamine concentrations Eleven out of the initial 12 volunteers (92%) returned for follow-up assessment at 6 months. The mean weight change observed at 6 months was 1.80 6 4.81 kg (P = 0.22 vs zero), with a mean FM change of 1.18 6 3.27 kg (P = 0.25) and a mean FFM change of 0.16 6 2.16 kg (P = 0.81). As previously reported (11) Baseline 24-hour urinary norepinephrine concentration (r = 0.69; P = 0.03; n = 10) and free T4 (r = 0.66; P = 0.03) measured during thermoneutrality were correlated with the change in FM at 6 months (Fig. 4) , such that a twofold increase in norepinephrine predicted a 3.0-kg (0.4 to 5.5) increase in FM and 0.1-mg/dL increase in free T4 predicted a 1.18-kg (0.17 to 2.19) increase in FM at 6 months. Normetanephrine (P = 0.10), metanephrine (P = 0.88), epinephrine (P = 0.55), and free T3 (P = 0.26) concentrations were not associated with FM change at 6 months.
Discussion
In 12 volunteers with CIBA, CIBA was negatively associated with markers of SNS activity and thyroid function measured during EBL and thermoneutrality, but not with 24hEE. As we previously reported, CIBA was negatively associated with baseline FFM and FM change at 6 months (11) (e.g., those with the highest CIBA had the lowest baseline FFM and lost FM at 6 months follow-up). In these same individuals, urinary catecholamine concentrations were positively associated with FM change at 6 months. Our data indicate a link between b n = 11 with urinary catecholamine measurements.
c n = 11 with 6-month follow-up body composition measurements.
lower norepinephrine concentration and CIBA, and both were predictors of FM gain. We hypothesize that a lower baseline sympathetic activity, as reflected by 24-hour urinary norepinephrine measures, indicates a greater capacity for both increasing sympathetic, and thus BAT, activation. This increased ability to activate CIBA then drives the protection against FM gain that we observed at 6 months. We suspect the observed associations among free T4, CIBA, and FM gain indicate similar physiology.
Contrary to previous studies, we observed CIBA to be negatively associated with FFM and did not find CIBA to be associated with age or adiposity measurements (3, 4, 10) , possibly due to the young age of our small cohort and its ethnic diversity (3, 12) . Because FFM is the most substantial determinant of EE (28), our results indicate that CIBA may not be an important predictor of EE during EBL and thermoneutrality after controlling for this confounder. Although prior studies have shown a positive association between BAT and EE during cold exposure (4, 6) , these studies used a hood system that allows for the measurement of EE during a brief period of cold exposure, as short as 20 minutes, and does not capture the physiologic conditions of meals and sleep. Our methodology using an initial acclimation chamber, measured during thermoneutrality, and the gold standard whole-room indirect calorimeter allowed for very precise measurement of 24hEE with the subject in EBL (EBL 12 6 61 kcal/d; P = 0.51 vs zero) prior to cold exposure to determine whether the baseline conditions influence BAT activation upon cold exposure. Although we did not find CIBA to be a determinant of thermoneutral and EBL EE, prior studies have assessed the contributions of BAT to overall EE. BAT has been reported to increase EE by 20% to 30% (4, 5) and involved in DIT at thermoneutrality (25) ; however, other studies have found minimal contribution of activated BAT to overall EE (29-31). Therefore, further larger studies are warranted to definitely determine the contribution of BAT in potentially combating obesity (32) .
Studies assessing catecholamine concentrations in settings in which BAT is not purposefully activated in humans have primarily been done in patients with pheochromocytomas, a medullary adrenal tumor that oversecretes catecholamines. PET/CTs performed in these patients to stage the disease have shown widespread BAT activation (17, 33, 34) . However, in a study with healthy subjects, plasma norepinephrine and its metabolite dihydroxyphenylglycol increased with cold exposure, but there were no differences in those catecholamines measured before and after cold stimulation in volunteers with positive vs negative CIBA (18) . In contrast, using 24-hour urinary concentrations instead of plasma measures, we demonstrated a negative association between CIBA and urinary norepinephrine measured during EBL and thermoneutrality in healthy individuals. Our results may suggest that lower sympathetic tone during EBL and thermoneutrality signify an increased ability to both activate SNS to some maximal threshold and recruit BAT upon cold exposure. One potential mechanism may be via an undersaturation of available beta-adrenergic receptors in BAT in individuals with lower sympathetic tone. Thus, those with lower SNS tone during thermoneutrality might have a greater potential to activate BAT during cold, requiring a lesser increase in norepinephrine from the SNS to do so.
In this cohort of individuals with positive CIBA, we also found a negative association between free T4 and CIBA such that individuals with higher BAT activity in response to cold had lower baseline free T4 measured during EBL and thermoneutrality. This association was in the same direction as that for urinary norepinephrine, which may be not surprising given the complex synergistic interactions of thyroid hormones and the adrenergic system (35) . The correlation with CIBA was observed only with free T4 and not with free T3; this could possibly be explained due to the relatively higher secretion of T4 from the thyroid and the lesser free T3 production by deiodinases during states of thermoneutrality and EBL (36) . In addition, free T3 conversion is tissue specific, and peripheral measurements may not be as reflective of the local free T3 action (37) that may be observed in BAT. Higher free T4 has been reported in BAT-negative subjects (19, 38) with normal thyroid function, in line with our cohort of positive CIBA individuals, in which those individuals with the lowest activation had the highest free T4. Therefore, in our cohort of BAT-positive subjects, our free T4 results may be due to our methodology in measuring thyroid function during thermoneutrality and EBL. The similar, yet independent, results between free T4 and urinary catecholamine concentrations with CIBA and future FM change seem to reflect a similar physiology.
The fact that the subjects at 6 months follow-up did not gain weight is not surprising, because our subjects were weight stable prior to admission to our unit. However, the variation in the change in FM is intriguing, and identifying intrinsic factors that predispose to fat gain in a small period of time may provide insight for identification of those prone to longer-term weight gain. Given our previous finding that greater CIBA predicted less FM gain at 6 months, we tested if body composition changes were also associated with urinary catecholamines or thyroid function measures. We found that both urinary norepinephrine and plasma free T4 measured in thermoneutrality and during EBL were positively associated with FM change at 6 months. As we noted earlier, it is possible that greater ability to activate brown fat leads to more fat utilization and therefore less fat storage. Thus, a lower urinary norepinephrine and free T4 state elicits a greater BAT response, and this could drive FM change. How BAT might affect FM change is unclear, as we did not find an association with baseline EE. However, diets with different macronutrient composition, specifically those with high carbohydrates, which are known to stimulate SNS, may activate BAT (39) . Because EE was not associated with CIBA in our study, it is also possible that CIBA might be evoking an effect on food intake.
Our study has several limitations. First, we have relatively small sample size; however, this cohort was carefully studied in a controlled inpatient clinical research unit, and our sample size provided enough power to assess for relationships between CIBA and both weight change and hormone measures. However, a larger sample of subjects is needed to verify if these are a conditional effect or an independent effect on future FM gain. We also did not have catecholamines or thyroid function tests collected during or after cold exposure, but these thermoneutral measurements may offer evidence of who has the potential to activate BAT and thus may have clinical and research utility. Lastly, there was no assessment of EE or dietary intake while subjects were in free-living condition, and therefore, we cannot directly assess why some individuals gained FM.
In conclusion, we found in individuals with CIBA, urinary norepinephrine concentrations and plasma free T4 measured during EBL and thermoneutrality were negatively .This series of images can be compared with the PET and CT and fused coronal PET/CT images (B) of the volunteer with the highest urinary norepinephrine and free T4 levels in the right panel, in which no visualization of CIBA is seen along with a mean SUV of 2.51 (g/mL), the lowest SUV in our cohort. associated with CIBA. Further, lower CIBA and higher baseline urinary norepinephrine and plasma free T4 concentrations predicted FM gain at 6 months. We propose that a higher SNS tone during EBL and thermoneutrality may signify a reduced ability to recruit BAT during cold exposure, thereby limiting any potential energy dissipating properties of BAT in these individuals. The use of catecholamines and thyroid hormones as a marker for potential BAT activation may help identify those who may derive benefit from the obesity opposing functions of BAT.
